Pancreatic Cancer Research

ResearcherFifth Hospital In WuhanNo recent work listed

Xiulan Peng

Matched on ORCID iD 0000-0001-8336-4253; OpenAlex author ID A5043836880.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis via the Wnt/β-Catenin Signaling Pathway. First author DOI 10.3389/fmed.2022.783592↗
  2. EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. Last author DOI 10.3892/etm.2015.2684↗
  3. EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. Last author DOI 10.3892/etm.2014.1831↗
  4. The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells. Co-author DOI 10.1007/s10735-012-9424-0↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Weiguo Dong · 3 shared papers, 2014–2022
  2. Mengyao Ji · 3 shared papers, 2012–2015
  3. Lei Yuan · 1 shared paper, 2015
  4. Weiguo Dong · 1 shared paper, 2012

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.